Effect of YAG Vitreolysis Laser treatment on vision-degrading vitreous floaters in short-sighted patients or patients with a posterior vitreous detachment
Read about the new study by @ProfStanga registered at #ISRCTN
https://t.co/QKxQwL378o
A great day discussing advances in gene therapy, cell therapy and implantables for treating inherited retinal diseases with esteemed experts and patients at #RetinaUKConf. Grateful to @RetinaUK for promoting retinal research in the UK! @tara_moore7@ProfStanga
The Ophthalmologist Power List 2023 highlights excellence and impact of the most influential and inspirational people in #Ophthalmology . Congratulations to @ProfStanga for being named on @OphthoMag Power List 2023. #Retina#Optometry
Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
Real-world outcomes of the novel compound faricimab demonstrated the efficacy and durability in nAMD patients.
https://t.co/1jlH7U111K
@ProfStanga#Ophthalmology#AMD
🙏🏻 to the Red Sea #Saudi Ophthalmology/RSOS 2022 Annual Meeting for inviting me to present our new work @RetinaLondon on Navigated OCT and on Ultra-Widefield Fluorescein and ICG Angiography with Simultaneous Navigated Peripheral Swept-Source OCT Imaging. #ophthalmology#optometry
@RetinaLondon is saddened by the passing of HM Queen Elizabeth II. Her leadership was second to none and the stability she provided to the country was vital during the decades of significant changes that her reign oversaw. May she rest in peace and God save the King
Excellent news for patients with #diabetic#macular oedema (DMO). Standard practice for some of us in Private Care. Should be widely available. Essential to discuss with patients all Treatment Options, Combination Therapy, Risks/Benefits & Cost. #Retina#Ophthalmology#Optometry
Annual Congress 2022 was a huge success!
94.2% of delegates rated their Congress experience as Excellent or Good!
If you missed Congress 2022, the sessions are still available to watch on-demand until 1st September. Registration is now open:
https://t.co/eao9paCr12.
All patients with type 1 diabetes in England are now eligible for life-changing continuous glucose monitors.
These monitors track a patient's glucose levels through a mobile app without having to scan or take a finger prick test. ➡️ https://t.co/hDSZCaLUff
Varied & choice of treatments for Exudative #AMD . After 1 year of 4-6 weekly Eylea intravitreal injections, a first new drug #Vabysmo#Faricimab injection (2 months ago): not only resolution of subretinal fluid but also flattening of subfoveal RPE. #ophthalmology#optometry
Thank You #BEYEONICS ™ for my trip to operate myself at Tel Aviv Medical center using the new digital 3D 𝗕𝗲𝘆𝗲𝗼𝗻𝗶𝗰𝘀 𝗢𝗻𝗲™ 𝗢𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗶𝗰 𝗘𝘅𝗼𝘀𝗰𝗼𝗽𝗲: "Immersive" intraocular experience. #retina#vitrectomy#ophthalmology#optometry https://t.co/Z1TtRrjsqL
We wellcome all attendees, speakers & exhibitors to our #Retina Day @RCOphth Annual Congress
We look forward to seeing you all today in person & virtually to discuss, amongst others, recently approved and in-the-pipeline new therapies as well as developments in imaging & surgery
I thoroughly enjoyed meeting with old and making new friends @RetinaWCongress#WRC2022 in Fort Lauderdale, learning from them and presenting our work on Navigated Widefield Cross-Sectional and 3-D Imaging of the Peripheral #retina and Vitreoretinal Interface.
Fantastic Congress!
We feel privileged to be part of the OAKS Study using Pegcetacoplan developed by @ApellisPharma to treat Geographic Atrophy in Dry #AMD#macular degeneration. Delivered as #Intravitreal Injection. #Optometry
A drug being trialled for dry age-related macular degeneration (AMD) can significantly reduce the progression of the disease, according to new studies. #Research
https://t.co/Afs4BxBMLO